{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:14:43Z","timestamp":1778404483853,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4231,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1046\/j.1469-0691.2003.00694.x","type":"journal-article","created":{"date-parts":[[2003,5,8]],"date-time":"2003-05-08T08:59:36Z","timestamp":1052384376000},"page":"333-338","source":"Crossref","is-referenced-by-count":33,"title":["Intravenous immunoglobulins in infectious diseases: where do we stand?"],"prefix":"10.1016","volume":"9","author":[{"given":"L.","family":"Mouthon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00694.x_bib1","series-title":"Ann Institut Pasteur\/actualit\u00e9s. he Retour de la s\u00e9roth\u00e9rapie","first-page":"49","article-title":"Immunoth\u00e9rapie passive des infections de l'h\u00f4te immunod\u00e9prim\u00e9","author":"Mouthon","year":"2001"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(84)90320-6","article-title":"Intravenous immune globulin therapy in hypogammaglobulinemia","volume":"76","author":"Pirofsky","year":"1984","journal-title":"A Rev Am J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib3","first-page":"335","article-title":"High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia","volume":"146","author":"Liese","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors","volume":"73","author":"Griffiths","year":"1989","journal-title":"Blood"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma","volume":"343","author":"Chapel","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.1992.03490040059026","volume":"268","author":"Mofenson","year":"1992","journal-title":"Jama"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib7","first-page":"44","article-title":"A controlled trial of long term administration of intravenous imunoglobulin to prevent late infection and chronic graft-versus host disease following bone marrow transplantation: clinical outcome and and effect on subsequent immune recovery","volume":"2","author":"Sullivan","year":"1995","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and anti-microbial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N Eng J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","article-title":"Manipulating the immune system with immune globulin","volume":"326","author":"Dwyer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-126-9-199705010-00008","article-title":"Intravenous Immune Globulin Therapy for neurologic diseases","volume":"126","author":"Dalakas","year":"1997","journal-title":"Ann Int Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1011012023616","article-title":"Diagnostic findings in 95 Finnish patients with common variable immunodeficiency","volume":"21","author":"Kainulainen","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-3083.2000.00697.x","article-title":"Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency","volume":"51","author":"Mullighan","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199411033311802","article-title":"A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group","volume":"331","author":"Spector","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib16","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1001\/archinte.1996.00440210053005","article-title":"A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection","volume":"156","author":"Kiehl","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1703109","article-title":"A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation","volume":"28","author":"Winston","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib18","first-page":"779a","article-title":"IV immune globulin prophylaxis in allogeneic sibling stem cell transplant patients: a randomized, dose-effect, placebo-controlled, double-blind, multicenter trial","volume":"98","author":"Cordonnier","year":"2001","journal-title":"Blood"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-118-12-199306150-00004","article-title":"High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group","volume":"118","author":"Wolff","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib20","first-page":"10","article-title":"Use of immune globulin to prevent symptomatic cytomegalovirusdisease in transplant recipients a meta-analysis","volume":"8","author":"Glowascki","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib21","first-page":"132","article-title":"A randomised trial of high dose polyvalent intraveinous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allooogenic hematopoietic stem cell transplants (HSCT)","volume":"83","author":"Zikos","year":"1998","journal-title":"Haemaiologica"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib22","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ajhp\/56.18.1831","article-title":"Comparison of ganciclovir- and immune globulin-containing regimens in preventing cytomegalovirus infection in patients with renal transplants","volume":"56","author":"Walton","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00336637","article-title":"Early detection of primary cytomegalovirus infection after heart and kidney transplantation and the influence of hyperimmune globulin prophylaxis","volume":"6","author":"Boland","year":"1993","journal-title":"Transpl Int"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83-121.2000","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0399-077X(98)80101-7","article-title":"Pr\u00e9vention des infections \u00e0 virus varicelle-zona","volume":"28s","author":"Geffray","year":"1998","journal-title":"M\u00e9d Mal Infect"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib27","first-page":"CD000361","article-title":"Intravenous immunoglobulin for preventing infection in preterm and\/or low-birth-weight infants","author":"Ohlsson","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199404213301602","article-title":"A controlled trial of intravenous immune globulin to reduce nosocomial infections in very low birth weight infants","volume":"330","author":"Fanaroff","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00007890-199310000-00011","article-title":"Parvovirus B19 infection in pediatric transplant patients","volume":"56","author":"Nour","year":"1993","journal-title":"Transplantation"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib30","first-page":"252","article-title":"Chronic pure red cell aplasia caused by parvovirus B19 in AIDS. use of intravenous immunoglobulin \u2013 a report of eight patients","volume":"89","author":"Koduri","year":"1994","journal-title":"Circulation"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib31","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1097\/00006454-198605010-00009","article-title":"Immunoglobulin supplementation in prevention or treatment of neonatal sepsis","volume":"5","author":"Sidiropoulos","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-999433","article-title":"Intravenous gammaglobulin as adjunct therapy for severe group B streptococcal disease in the newborn","volume":"7","author":"Friedman","year":"1990","journal-title":"Am J Perinatol"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3476(05)83389-X","article-title":"Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis","volume":"118","author":"Christensen","year":"1991","journal-title":"J Pediatr"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0163-4453(92)90870-C","article-title":"Virus infections of the respiratory tract in HIV infected children","volume":"24","author":"Hague","year":"1992","journal-title":"J Infect"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib35","first-page":"CD001239","article-title":"Intravenous immunoglobulin for suspected or subsequently proven infection in neonates","author":"Ohlsson","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib36","first-page":"CD001090","article-title":"Intravenous immunoglobulin for treating sepsis and septic shock","author":"Alejandria","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-109-10-777","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin","volume":"109","author":"Emanuel","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-109-10-783","article-title":"Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants","volume":"109","author":"Reed","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome \u2013 a comparative observational study. The Can Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib40","first-page":"533","article-title":"[Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]","volume":"151","author":"Larroche","year":"2000","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","article-title":"Intravenous immunoglobulin therapy for severe Clostridium difficile colitis","volume":"41","author":"Salcedo","year":"1997","journal-title":"Gut"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"i","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<127::AID-AJH5>3.0.CO;2-#","article-title":"Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS","volume":"59","author":"Majluf-Cruz","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/adc.79.1.48","article-title":"Immunoglobulin replacement treatment by rapid subcutaneous infusion","volume":"79","author":"Gaspar","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1046\/j.1469-0691.2003.00694.x_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","article-title":"The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy","volume":"20","author":"Chapel","year":"2000","journal-title":"J Clin Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14631268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14631268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T20:06:06Z","timestamp":1584648366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14631268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S1198743X14631268"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00694.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}